Evolent Health, Inc.

Symbol: EVH

NYSE

31.93

USD

Market price today

  • -27.0907

    P/E Ratio

  • 0.0237

    PEG Ratio

  • 3.69B

    MRK Cap

  • 0.00%

    DIV Yield

Evolent Health, Inc. (EVH) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.23%

Operating Profit Margin

-0.03%

Net Profit Margin

-0.06%

Return on Assets

-0.04%

Return on Equity

-0.10%

Return on Capital Employed

-0.03%

Company general description and statistics

Sector: Healthcare
Industry: Healthcare - Information Services
CEO:Mr. Seth Barrie Blackley
Full-time employees:4700
City:Arlington
Address:800 North Glebe Road
IPO:2015-06-05
CIK:0001628908

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

General Outlook

When we look at how much money they make before expenses, they keep 0.234% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.032%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.058%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.042% return, is a testament to Evolent Health, Inc.'s adeptness in optimizing resource deployment. Evolent Health, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.103%. Furthermore, the proficiency of Evolent Health, Inc. in capital utilization is underscored by a remarkable -0.031% return on capital employed.

Stock Prices

Evolent Health, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $28.13, while its low point bottomed out at $27.27. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Evolent Health, Inc.'s stock market.

Liquidity Ratios

Analyzing EVH liquidity ratios reveals its financial health of the firm. The current ratio of 101.40% gauges short-term asset coverage for liabilities. The quick ratio (96.90%) assesses immediate liquidity, while the cash ratio (28.60%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio101.40%
Quick Ratio96.90%
Cash Ratio28.60%

Profitability Ratios

EVH profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -10.31% underscores its earnings before tax deductions. The effective tax rate stands at 44.15%, revealing its tax efficiency. The net income per EBT, 55.85%, and the EBT per EBIT, 323.11%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -3.19%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-10.31%
Effective Tax Rate44.15%
Net Income per EBT55.85%
EBT per EBIT323.11%
EBIT per Revenue-3.19%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.01, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding97
Operating Cycle83.03
Days of Payables Outstanding12
Cash Conversion Cycle71
Receivables Turnover4.40
Payables Turnover31.16
Inventory Turnover1503426000.00
Fixed Asset Turnover21.78
Asset Turnover0.73

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.26, and free cash flow per share, 1.00, depict cash generation on a per-share basis. The cash per share value, 1.82, showcases liquidity position. A payout ratio of -0.17 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.07, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.26
Free Cash Flow per Share1.00
Cash per Share1.82
Payout Ratio-0.17
Operating Cash Flow Sales Ratio0.07
Free Cash Flow to Operating Cash Flow Ratio0.80
Cash Flow Coverage Ratio0.22
Short Term Coverage Ratio14.64
Capital Expenditure Coverage Ratio4.96
Dividend Paid and Capex Coverage Ratio3.00
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 24.06%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.60, we discern the balance between debt and equity financing. The long-term debt to capitalization, 37.30%, and total debt to capitalization, 37.65%, ratios shed light on its capital structure. An interest coverage of -1.16 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio24.06%
Debt Equity Ratio0.60
Long Term Debt to Capitalization37.30%
Total Debt to Capitalization37.65%
Interest Coverage-1.16
Cash Flow to Debt Ratio0.22
Company Equity Multiplier2.51

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 17.65, provides a glimpse into top-line earnings distributed across each share. Net income per share, -1.02, reflects the portion of profit attributed to each share. The book value per share, 9.60, represents the net asset value distributed per share, while the tangible book value per share, -7.20, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share17.65
Net Income Per Share-1.02
Book Value Per Share9.60
Tangible Book Value Per Share-7.20
Shareholders Equity Per Share9.60
Interest Debt Per Share6.28
Capex Per Share-0.26

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 45.26%, indicates top-line expansion, while the gross profit growth, 45.45%, reveals profitability trends. EBIT growth, -19.01%, and operating income growth, -19.01%, offer insights into operational profitability progression. The net income growth, -504.46%, showcases bottom-line expansion, and the EPS growth, -410.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth45.26%
Gross Profit Growth45.45%
EBIT Growth-19.01%
Operating Income Growth-19.01%
Net Income Growth-504.46%
EPS Growth-410.00%
EPS Diluted Growth-410.00%
Weighted Average Shares Growth18.73%
Weighted Average Shares Diluted Growth18.73%
Dividends per Share Growth6.34%
Operating Cash Flow Growth1334.16%
Free Cash Flow Growth328.07%
10-Year Revenue Growth per Share2528.69%
5-Year Revenue Growth per Share117.72%
3-Year Revenue Growth per Share46.63%
10-Year Operating CF Growth per Share459.47%
5-Year Operating CF Growth per Share579.97%
3-Year Operating CF Growth per Share770.85%
10-Year Net Income Growth per Share-293.98%
5-Year Net Income Growth per Share-49.23%
3-Year Net Income Growth per Share74.18%
10-Year Shareholders Equity Growth per Share1081.78%
5-Year Shareholders Equity Growth per Share-35.11%
3-Year Shareholders Equity Growth per Share31.55%
3-Year Dividend per Share Growth per Share-28.27%
Receivables Growth75.41%
Inventory Growth100.00%
Asset Growth47.49%
Book Value per Share Growth4.63%
Debt Growth35.43%
R&D Expense Growth-1.11%
SGA Expenses Growth32.99%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,126,591,530, captures the company's total value, considering both debt and equity. Income quality, -1.26, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 69.71%, indicates the value of non-physical assets, and capex to operating cash flow, -20.16%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value4,126,591,530
Income Quality-1.26
Research and Development to Revenue1.36%
Intangibles to Total Assets69.71%
Capex to Operating Cash Flow-20.16%
Capex to Revenue-1.46%
Capex to Depreciation-23.29%
Stock-Based Compensation to Revenue2.06%
Graham Number14.81
Return on Tangible Assets-13.93%
Graham Net Net-9.63
Working Capital9,431,000
Tangible Asset Value-800,850,000
Net Current Asset Value-928,934,000
Invested Capital1
Average Receivables350,716,500
Average Payables52,710,000
Average Inventory-207,962,999.5
Days Sales Outstanding83
Days Payables Outstanding12
ROIC-2.32%
ROE-0.11%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.87, and the price to book ratio, 2.87, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.60, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 27.52, and price to operating cash flows, 21.48, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.87
Price to Book Ratio2.87
Price to Sales Ratio1.60
Price Cash Flow Ratio21.48
Price Earnings to Growth Ratio0.02
Enterprise Value Multiple57.80
Price Fair Value2.87
Price to Operating Cash Flow Ratio21.48
Price to Free Cash Flows Ratio27.52
Price to Tangible Book Ratio3.44
Enterprise Value to Sales2.10
Enterprise Value Over EBITDA88.97
EV to Operating Cash Flow28.94
Earnings Yield-3.08%
Free Cash Flow Yield3.10%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Evolent Health, Inc. (EVH) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -27.091 in 2024.

What is the ticker symbol of Evolent Health, Inc. stock?

The ticker symbol of Evolent Health, Inc. stock is EVH.

What is company IPO date?

IPO date of Evolent Health, Inc. is 2015-06-05.

What is company current share price?

Current share price is 31.930 USD.

What is stock market cap today?

The market cap of stock today is 3685679900.000.

What is PEG ratio in 2024?

The current 0.024 is 0.024 in 2024.

What is the number of employees in 2024?

In 2024 the company has 4700.